22 min listen
Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?
Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?
ratings:
Length:
21 minutes
Released:
Jan 17, 2024
Format:
Podcast episode
Description
Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies. Credit available for this activity expires: 1/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999658?ecd=bdc_podcast_libsyn_mscpedu
Released:
Jan 17, 2024
Format:
Podcast episode
Titles in the series (100)
The Latest in PAD: Guidelines, Data, and Expert Interpretation: Dr Bauersachs, Brodmann, and Aboyans review the latest recommendations antithrombotic therapy in patients with PAD. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current CME